PharmTech News

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Articles

The company received priority review for its investigational CAR-T therapy to treat leukemia.

Novartis Receives FDA Priority Review for CAR-T Therapy

Randi Hernandez was science editor at BioPharm International from September 2014 to May 2017.

The mAb is the first approved treatment that targets the progressive form of the disease.

FDA Approves First Treatment for Primary-Progressive Forms of Multiple Sclerosis

The company has signed two separate agreements with the Agency for Science, Technology, and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.

Plasticell Collaborates with Singaporean Institutions on Stem Cell Research

FDA approved Dupixent for the treatment of atopic dermatitis amidst a preemptive lawsuit filed by Sanofi/Regeneron involving the drug and an Amgen patent covering IL-4 inhibitors.

FDA Approves Dupixent for Atopic Dermatitis

The Basel office will house the clinical development team and other functions to progress the company’s lead compound emapalumab.

Novimmune Opens Branch Office in Basel

FDA approved avelumab for the treatment of patients with Merkel cell carcinoma.

FDA Approves Avelumab for Rare Skin Cancer

The company said it plans to expand diabetes manufacturing facilities in the United States.

Lilly Invests $850 Million in US Manufacturing Operations

Sanofi and Regeneron are asking a federal court to issue a judgment of non-infringement for Amgen’s ‘487 patent.

Sanofi and Regeneron File Suit Against Amgen in Patent Case

The companies will be expanding their collaboration to discover novel therapies that will include up to eight additional targets using CytomX’s proprietary Probody platform.

BMS and CytomX Expand Collaboration

The company said that it has successfully completed its first in-orbit experiment using its miniature end-to-end space laboratory.

Bio/Pharma News